Skip to content

H Furukawa

6 papers in the library · 141 citations · publishing 1984-1994

Papers

Sort Most recent Most cited

Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin.

Japanese journal of pharmacology October 1994 K Kitaichi, K Yamada, T Hasegawa et al.

In this study, we investigated whether risperidone, a serotonin-S2A (5-HT2A)/dopamine-D2 (D2)-receptor antagonist, inhibits phencyclidine (PCP)-induced stereotyped behaviors in comparison with haloperidol and ritanserin. Moreover, we also attempted to investigate the effects of these antipsychotics on the contents of dopamine, serotonin (5-HT) and their metabolites in rat striatum and frontal...

Phencyclidine-induced head-weaving observed in mice after ritanserin treatment.

European Journal of Pharmacology July 9, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 17 citations

Ritanserin (0.125, 0.25, 0.5, 1.0 and 2.0 mg/kg s.c.), a selective serotonin (5-HT2) receptor antagonist, produced a dose-dependent inhibition of the head-twitch response induced in mice by phencyclidine (PCP) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). In contrast, ritanserin, dose dependently increased PCP- and 5-MeODMT-induced head-weaving. There was a significant inverse relationship...

Phencyclidine-induced head-twitch responses as 5-HT2 receptor-mediated behavior in rats.

Neuroscience Letters May 19, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 27 citations

This study was designed to assess whether phencyclidine (PCP)-induced head-twitch was antagonized by ritanserin, a selective serotonin (5-HT2) receptor antagonist, in mice and rats to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions in comparison with 5-methoxy-N,N-dimethyltryptamine (5-MeODMT)-induced behavior. PCP (7.5, 10 and 12.5 mg/kg, i.p.)-induced head-twitch...

Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.

European Journal of Pharmacology March 3, 1987 Toshitaka Nabeshima, H Fukaya, K Yamaguchi et al. 70 citations

In rats treated with phencyclidine (PCP) repeatedly (PCP 10 mg/kg per day for 14 days), the back-pedalling, head-weaving and turning induced by PCP were attenuated (tolerance), while PCP-induced sniffing, rearing and ambulation were potentiated (supersensitivity). The behavior induced by the direct and indirect serotonin (5-HT) agonists, 5-methoxy-N,N-dimethyltryptamine and p-chloroamphetamine,...

Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.

European Journal of Pharmacology January 20, 1987 Toshitaka Nabeshima, K Ishikawa, K Yamaguchi et al. 27 citations

This study was designed to assess whether phencyclidine (PCP)-induced behaviors in rats were potentiated after two days' withdrawal from chronic methysergide (a 5-HT2 receptor blocker) treatment (10 mg/kg per day i.p. for 12 days), in order to confirm the involvement of 5-hydroxytryptamine (5-HT) neurons in PCP actions. The PCP (10 mg/kg)-induced behaviors (head-twitch, head-weaving, turning...

Serotonergic involvement in phencyclidine-induced behaviors.

Pharmacology, biochemistry, and behavior September 1984 T Nabeshima, K Yamaguchi, M Hiramatsu et al.

Administration of 5-10 mg/kg of phencyclidine (PCP) caused stereotyped behaviors including sniffing, backpedalling, head weaving and turning in rats. The PCP-induced stereotyped behaviors (backpedalling, head weaving and turning) were attenuated by serotonin (5-HT) depleters [reserpine, p-chlorophenylalanine, p-chloroamphetamine (PCA)] and 5-HT receptor antagonist (cyproheptadine). PCP-induced...